Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Acta Pharmacologica Sinica
1671-4083
1998 Issue S1
disease paterns and trends in asia
..............page:7-8
assesment of equivalence on mulltiple endpoints
quan hui ; long jian ming ; yuan wei ying ;
..............page:30-31
estimation of bioequivalence parameters
zhou xian zhong ; shao jun ; wang wu bao ;
..............page:30
research ethics and common sense
..............page:38
eortc quality-of-life assesment in an asia-pacific hepatocellular carcinoma trial
dai mei zhu ; zhou jia hao ; lin jing fang ; su qi zhi ;
..............page:84
educational needs in clinical trials research methodology
lv wei fen ;
..............page:77-78
confounder and its criteria in epidemiological studies
feng rong jin ; guo jian hua ; geng zhi ;
..............page:32
effectiveness of intervention by a geriatric outreach rehabilitation team to nursing home inmates
mo jun qiang ; liang bi zuo ; qu shi ren ;
..............page:83
use of sertraline(an ssri) in chinese elderly stroke patients with depression
mo jun qiang ; mai zhao qiang ; liang jing cheng ; qu shi ren ;
..............page:50
psychometric and clinical evaluation of chinese version of sf-36 health survey among cancer patients in china
ren xin hua ; wang xin ; liu shu jun ; hao xi shan ;
..............page:22
prevalence of childhood asthma,allergic rhinitis,and eczema among urumqi,beijing,andhong kong
zhao tie bing ; liu yu long ; chen yu zhi ; wang hai jun ; xiao man lin ; duo li kun ; liu gang ;
..............page:82
epidemiology of diabetes mellitus in children in hong kong-the hong kong childhood diabetes register
bi hui wen ; zhang jing an ; zhang zhi xiong ; zhang bi tao ; jia shi bo ; guan yan hua ; lin xiao ling ; lin wan zuo ; li hui zuo ; lu zhong qi ; chen jun ming ; xie zuo yi ; zhang xiu xiang ; huang yong jian ; huang li ming ; yang jun zuo ; yu ze wen ;
..............page:23
drug regulations and gcp in china
ding jian hua ;
..............page:33-34
overview of hypertension trials
..............page:45
baseline imbalance caused by stratified random sampling
zhong cun gang ; chi ze hong ping ; juan chuan zhi zi ; ye zuo shan ming ;
..............page:69-70
erythromycin reduces bronchorhoea and improves lung function in bronchiectasis
zeng hua de ; he bai liang ; chen guo ning ; ye xiu wen ; lin hua jie ;
..............page:88
academic merits of clinical trials
..............page:75
epidemiology of respiratory disease-the asian perspective
lin da qing ; he shi xian ;
..............page:11-12
clinical trials in japan-new gcp
wang yue jing ;
..............page:34
oral levofloxacin versus intravenous ceftazidime in bronchiectasis exacerbation
zeng hua de ; he bai liang ; chen hui ming ; lin hua jie ; ye xiu wen ;
..............page:89
the hypertension optimal study
..............page:55-56
interval estimation in meta-analysis
yang liang he ;
..............page:31
incidence rate and associations of depression in chinese elderly stroke patients undergoing rehabilitation
mo jun qiang ; mai zhao qiang ; liang jing cheng ; qu shi ren ;
..............page:18
inhaled fluticasone reduces sputum inflammation in chronic bronchial sepsis
zeng hua de ; he bai liang ; ye xiu wen ; lin hua jie ;
..............page:54
asian randomized clinical trials in medline 1990-1997
ou yong ping ; ye ke gang ;
..............page:93
gcp development and compliance in asia
zhang jun ;
..............page:35-37
informed consent from an asian perspective
lin cheng yi ;
..............page:38-40
why do clinical trials in asia?
lin zhao zuo ;
..............page:6
mobility and self-concept for patients after cardiac surgery
wu wan yi ; tan sheng hui ; zheng li xiang ; zhao rui hua ;
..............page:20
a twenty-six-week trial of thymosin 1 plus famciclovir in the treatment of chinese immune tolerantadult patients with chronic hepatitis b
liao jia jie ; guo zuo zuo ; li xi tao ; lin zuo ling ; liang ying jie ; lin zhao zuo ;
..............page:49
principles of meta-analysis
..............page:41-42
priorities for the improvement of clinical trials in asia
huang zhi lie ;
..............page:76
sample sizes in survival studies
..............page:67-68
pharmacokinetics of some antimicrobials in asian patients
zheng chao zuo ;
..............page:14